Bristol-Myers Squibb Company (NYSE: BMY) stock closed at 65.46 per share at the end of the most recent trading day (a 1.58% change compared to the prior day closing price) with a volume of 14.59M shares and market capitalization of 146.79B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 30250 people. Bristol-Myers Squibb Company CEO is Giovanni Caforio.

The one-year performance of Bristol-Myers Squibb Company stock is 8.19%, while year-to-date (YTD) performance is 5.53%. BMY stock has a five-year performance of -3.3%. Its 52-week range is between 54.07 and 67.16, which gives BMY stock a 52-week price range ratio of 88.92%

Bristol-Myers Squibb Company currently has a PE ratio of -15.50, a price-to-book (PB) ratio of 3.66, a price-to-sale (PS) ratio of 4.41, a price to cashflow ratio of 9.90, a PEG ratio of 2.32, a ROA of -6.94%, a ROC of 1.35% and a ROE of -19.18%. The company’s profit margin is -26.65%, its EBITDA margin is 11.60%, and its revenue ttm is $31.74 Billion , which makes it $14.21 revenue per share.

Of the last four earnings reports from Bristol-Myers Squibb Company, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.82 for the next earnings report. Bristol-Myers Squibb Company’s next earnings report date is 29th Apr 2021.

The consensus rating of Wall Street analysts for Bristol-Myers Squibb Company is Moderate Buy (1.77), with a target price of $74.3, which is +13.54% compared to the current price. The earnings rating for Bristol-Myers Squibb Company stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bristol-Myers Squibb Company has a dividend yield of 3.13% with a dividend per share of $1.96 and a payout ratio of 273.00%.

Bristol-Myers Squibb Company has a Buy technical analysis rating based on Technical Indicators (ADX : 4.96, ATR14 : 1.41, CCI20 : 225.19, Chaikin Money Flow : 0.17, MACD : 0.62, Money Flow Index : 54.06, ROC : 3.40, RSI : 62.71, STOCH (14,3) : 95.45, STOCH RSI : 1.00, UO : 65.46, Williams %R : -4.55), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bristol-Myers Squibb Company in the last 12-months were: Adam Dubow (Option Excercise at a value of $0), Adam Dubow (Sold 4 100 shares of value $252 283 ), Christopher S. Boerner (Option Excercise at a value of $0), David V. Elkins (Option Excercise at a value of $0), Dinesh C. Paliwal (Buy at a value of $999 966), Elizabeth A. Mily (Option Excercise at a value of $0), Giovanni Caforio (Option Excercise at a value of $0), Giovanni Caforio (Sold 64 840 shares of value $4 052 968 ), Joseph Eid (Option Excercise at a value of $0), Joseph Eid (Sold 5 327 shares of value $340 928 ), Julia A. Haller (Option Excercise at a value of $0), Karen Murphy Santiago (Option Excercise at a value of $0), Louis S. Schmukler (Option Excercise at a value of $0), Louis S. Schmukler (Sold 25 000 shares of value $1 567 000 ), Michael W. Bonney (Option Excercise at a value of $0), Nadim Ahmed (Option Excercise at a value of $0), Paul von Autenried (Option Excercise at a value of $0), Paul von Autenried (Sold 20 003 shares of value $1 255 191 ), Powell Ann Judge (Option Excercise at a value of $0), Rupert Vessey (Option Excercise at a value of $4 360 456), Rupert Vessey (Sold 142 024 shares of value $8 707 026 ), Samit Hirawat (Option Excercise at a value of $0), Sandra Leung (Option Excercise at a value of $0), Sandra Leung (Sold 141 420 shares of value $8 943 401 )